Martin Krehenbrink und Biotechnological - Info zur Person

(1 - 8 von 8

)

LinkedIn: Martin Krehenbrink – Produktionsleiter – Bind-X GmbH ...de.linkedin.com › martin-krehenbrink-9a › de-de

Martin Krehenbrink. Biotechnological process development. Bind-X GmbHJohn Innes Centre. Planegg, Bayern, Deutschland292 Kontakte.

Cysal - Company ProfileTracxn

tracxn.com

Cysal - Biotechnological production of dipeptides. Raisedfunding over 1 round from 2 investors. Founded by Martin Krehenbrink in the year

Cysal | Tracxn

tracxn.com

Founded by Martin Krehenbrink in the year · Ahmed Sallam, eCAPITAL, Stroetmann are among its shareholders · Biotechnological production of dipeptides. › Cysal

Industrial biocatalysis (Pan Stanford Publishing): 2015国立国会図書館

iss.ndl.go.jp

Biotechnological approaches to dipeptide production / Martin Krehenbrink, Ahmed Sallam, and Alexander Steinbüchel Synthetic enzyme cascades for ...

Industrial Biocatalysis - Seite Google Books-Ergebnisseitegoogle.de

books.google.de

Chapter 23 Biotechnological Approaches to Dipeptide Production Martin Krehenbrink,a Ahmed Sallam,a and Alexander Steinbüchelb,c aCysal GmbH, Mendelstr.